
OPC-51803
CAS No. 192514-54-8
OPC-51803( —— )
Catalog No. M34361 CAS No. 192514-54-8
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 532 | Get Quote |
![]() ![]() |
5MG | 787 | Get Quote |
![]() ![]() |
10MG | 1074 | Get Quote |
![]() ![]() |
25MG | 1463 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
500MG | 4410 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameOPC-51803
-
NoteResearch use only, not for human use.
-
Brief DescriptionOPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
-
DescriptionOPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetVasopressin Receptor
-
RecptorVasopressin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number192514-54-8
-
Formula Weight454
-
Molecular FormulaC26H32ClN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(N1C=2C([C@@H](CC(NC(C)C)=O)CCC1)=CC=CC2)C3=C(Cl)C=C(C=C3)N4CCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
OPC-51803
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.
-
Balovaptan
Balovaptan is a highly potent and selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist.
-
Desmopressin acetate
Desmopressin is the synthetic analog of the antidiuretic hormone arginine vasopressin. Vasopressin Receptor The antidiuretic properties of desmopressin have led to its use in polyuric conditions including primary nocturnal enuresis nocturia and diabetes insipidus.